NO20065792L - Fremgangsmate for formulering for transdermal avlevering av immunologisk aktive midler - Google Patents

Fremgangsmate for formulering for transdermal avlevering av immunologisk aktive midler

Info

Publication number
NO20065792L
NO20065792L NO20065792A NO20065792A NO20065792L NO 20065792 L NO20065792 L NO 20065792L NO 20065792 A NO20065792 A NO 20065792A NO 20065792 A NO20065792 A NO 20065792A NO 20065792 L NO20065792 L NO 20065792L
Authority
NO
Norway
Prior art keywords
immunologically active
active agent
formulation
procedure
active agents
Prior art date
Application number
NO20065792A
Other languages
English (en)
Norwegian (no)
Inventor
Mahmoud Ameri
Yuh-Fun Maa
Scott Sellers
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20065792L publication Critical patent/NO20065792L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
NO20065792A 2004-05-19 2006-12-14 Fremgangsmate for formulering for transdermal avlevering av immunologisk aktive midler NO20065792L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57286104P 2004-05-19 2004-05-19
PCT/US2005/014008 WO2005112463A2 (en) 2004-05-19 2005-04-21 Method and formulation for transdermal delivery of immunologically active agents

Publications (1)

Publication Number Publication Date
NO20065792L true NO20065792L (no) 2007-02-14

Family

ID=35394844

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065792A NO20065792L (no) 2004-05-19 2006-12-14 Fremgangsmate for formulering for transdermal avlevering av immunologisk aktive midler

Country Status (13)

Country Link
US (1) US20050266011A1 (ja)
EP (1) EP1747672A4 (ja)
JP (1) JP2008507590A (ja)
CN (1) CN101433091A (ja)
AR (1) AR049053A1 (ja)
AU (1) AU2005242409A1 (ja)
CA (1) CA2566759A1 (ja)
IL (1) IL179378A0 (ja)
MX (1) MXPA06013490A (ja)
NO (1) NO20065792L (ja)
TW (1) TW200608992A (ja)
WO (1) WO2005112463A2 (ja)
ZA (1) ZA200610654B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020193729A1 (en) * 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
GB0505518D0 (en) * 2005-03-17 2005-04-27 Chiron Srl Combination vaccines with whole cell pertussis antigen
US8168206B1 (en) * 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
CA2801151A1 (en) * 2010-06-01 2011-12-08 Novartis Ag Concentration of vaccine antigens with lyophilization
KR102471356B1 (ko) * 2010-06-01 2022-11-28 노파르티스 아게 동결건조하지 않는 인플루엔자 백신 항원의 농축
AU2011290471B2 (en) 2010-08-20 2015-08-20 Novartis Ag Soluble needle arrays for delivery of influenza vaccines
US20120219590A1 (en) * 2011-02-24 2012-08-30 Paxvax, Inc. Formulations useful for spray drying vaccines
GB201106802D0 (en) 2011-04-21 2011-06-01 Allergy Therapeutics Ltd Process for preparing vaccine composition
JP2015091791A (ja) * 2013-10-03 2015-05-14 日東電工株式会社 インフルエンザワクチン乾燥製剤、及び、インフルエンザワクチン乾燥製剤の製造方法
US20160310412A1 (en) * 2013-12-16 2016-10-27 Takeda Pharmaceutical Company Limited Microneedle
ES2755815T3 (es) 2016-09-13 2020-04-23 Allergan Inc Composiciones de toxina de Clostridium no proteicas estabilizadas
US11306292B2 (en) * 2017-05-15 2022-04-19 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
MX2021000548A (es) * 2018-07-19 2021-07-02 Glaxosmithkline Biologicals Sa Procesos para preparar polisacáridos en seco.
JP2023522699A (ja) * 2020-04-22 2023-05-31 エマージェクス ユーエスエー コーポレーション コロナウイルスワクチンでコーティングされた微小突起を有する経皮活性剤送達デバイス

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3964482A (en) * 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (fr) * 1972-02-14 1973-08-13 Ici Ltd Pansements
GB1488800A (en) * 1973-11-29 1977-10-12 Wellcome Found Influenza vaccines
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5147296A (en) * 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
AU5740496A (en) * 1995-05-22 1996-12-11 General Hospital Corporation, The Micromechanical device and method for enhancing delivery of compounds through the skin
AU3399197A (en) * 1996-06-18 1998-01-07 Alza Corporation Device for enhancing transdermal agent delivery or sampling
ATE302041T1 (de) * 1997-12-11 2005-09-15 Alza Corp Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
WO1999029364A1 (en) * 1997-12-11 1999-06-17 Alza Corporation Device for enhancing transdermal agent flux
US6091975A (en) * 1998-04-01 2000-07-18 Alza Corporation Minimally invasive detecting device
US6284282B1 (en) * 1998-04-29 2001-09-04 Genentech, Inc. Method of spray freeze drying proteins for pharmaceutical administration
MXPA03003815A (es) * 2000-10-26 2004-08-12 Johnson & Johnson Dispositivos de suministro transdermico de farmaco que tienen microrresaltos recubiertos.
US6855372B2 (en) * 2001-03-16 2005-02-15 Alza Corporation Method and apparatus for coating skin piercing microprojections
US20020193729A1 (en) * 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
WO2003049670A2 (en) * 2001-07-27 2003-06-19 Immuno-Rx, Inc. Adjuvant formulations for bacterial and virus vaccines and method of making same
AU2003221888B2 (en) * 2002-04-11 2008-11-06 Medimmune, Llc Preservation of bioactive materials by spray drying
CA2562932A1 (en) * 2004-04-01 2005-10-27 Alza Corporation Apparatus and method for transdermal delivery of influenza vaccine
MXPA06011971A (es) * 2004-04-13 2007-04-16 Johnson & Johnson Aparato y metodo para suministro transdermico de multiples vacunas.

Also Published As

Publication number Publication date
WO2005112463A2 (en) 2005-11-24
US20050266011A1 (en) 2005-12-01
ZA200610654B (en) 2008-06-25
CA2566759A1 (en) 2005-11-24
JP2008507590A (ja) 2008-03-13
CN101433091A (zh) 2009-05-13
AR049053A1 (es) 2006-06-21
WO2005112463A3 (en) 2009-05-14
IL179378A0 (en) 2007-03-08
TW200608992A (en) 2006-03-16
EP1747672A2 (en) 2007-01-31
AU2005242409A1 (en) 2005-11-24
MXPA06013490A (es) 2007-06-12
EP1747672A4 (en) 2010-02-17

Similar Documents

Publication Publication Date Title
NO20065792L (no) Fremgangsmate for formulering for transdermal avlevering av immunologisk aktive midler
MX2022006672A (es) Compuestos bifuncionales para la degradacion de btk a traves de la via de proteosomas de ubiquitina.
WO2012112699A3 (en) Method and apparatus for the delivery of photo-chemical (cross-linking) treatment to corneal tissue
NO20063373L (no) CD40-antistoff-formuleringer og fremgangsmater
NO20061674L (no) Sterilisering ved hoyt trykk for avsluttende sterilisering av farmasoytiske preparater og medisinske produkter
AR086409A1 (es) Formulaciones de gel bioadhesivo de testosterona intranasal y uso del mismo para tratar hipogonadismo masculino
WO2007008257A3 (en) Method and apparatus for delivering epinephrine
UA115131C2 (uk) Сполуки боронатного ефіру і його фармацевтичні рецептури
WO2005099751A3 (en) Apparatus and method for transdermal delivery of influenza vaccine
FR2827605B1 (fr) Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
NO20082988L (no) Vedvarende frigivningsformulering innbefattende oktreotid og to eller flere polylaktid-ko-glykolidpolymerer
CR10766A (es) Inhibidores de metaloproteasa derivados de heterociclicos
NO20082477L (no) Krystallinske former av 1-benzoyl-4-[2-[4-metoksy-7-(3-metyl-1H-1,2,4-triazol-1-yl-1-[(fosfonooksy)metyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioksoetyl]-piperazin
NZ744233A (en) Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
NO20080936L (no) Transdermale medikamentleveringsinnretninger inneholdende O-desmetylvenlafaksin (ODV) eller salter derav
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
MX2013012206A (es) Metodo para producir substancias con gas sobresaturado,dispositivo de suministro transdermico de las mismas, y usos de las mismas.
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
DK1471936T3 (da) HIV-Vaccine og fremgangsmåde til anvendelse
AU2018282105A1 (en) Dosing of vibegron for treatment of overactive bladder
HK1106447A1 (en) Liquid allergy vaccine formulation for oromucosal administration
NO20052313L (no) Vandig farmasoytisk formulering omfattende trombininhibitorer melagatran og anvendelse av formuleringen for fremstilling av et medikament for anvendelse i nasal administrering i behandling av
MX2013012204A (es) Metodo para producir substancias con gas sobresaturado, dispositivo de suministro transdermico de las mismas, y usos de las mismas.
WO2019087133A8 (en) Method of treating tendinopathy using interleukin-17 (il-17) antagonists
MX2013012205A (es) Metodo para producir substancias con gas sobresaturado, dispositivo de suministro transdermico de las mismas, y usos de las mismas.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application